EndoTool SubQ
Overview
EndoTool SubQ, developed by Monarch Medical Technologies (now part of Glooko as of September 23, 2025), is a software application designed to provide clinical decision support for subcutaneous insulin administration. It is used to manage blood glucose levels in both adult and pediatric patients (age 2 years and above and 12 kg or more). The tool utilizes proprietary model predictive control technology and feedback mathematics to model, predict, and adjust to each patient’s unique physiology and individual response to insulin, recommending the safest, most effective patient-specific dose.
EndoTool SubQ considers various factors that impact insulin response, including blood glucose level, height, weight, type of diabetes mellitus, age, sex, creatinine levels, steroids, carbohydrate intake, and ordered insulin. The software aims to reduce and eliminate correctional dosing, promote mealtime dosing, and prevent hypoglycemia by recommending supplemental carbohydrates if needed. As part of the broader EndoTool platform, it facilitates safe and easy transitions between intravenous and subcutaneous insulin therapies. The technology originated in 2003 with MD Scientific, which laid the groundwork for the EndoTool glucose management system.
Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Key Features
- Patient-specific insulin dosing recommendations
- Model predictive control technology
- Feedback mathematics for modeling and predicting insulin response
- Adjusts to individual patient physiology
- Considers various patient factors (BG, height, weight, diabetes type, age, sex, creatinine, steroids, carb intake, ordered insulin)
- Reduces and eliminates correctional dosing
- Promotes mealtime dosing
- Recommends supplemental carbohydrates for hypoglycemia prevention
- Supports adult and pediatric patients (age 2 and above)
- Seamless transition between IV and SubQ insulin therapies (as part of EndoTool platform)
Use Cases
- Inpatient subcutaneous insulin management
- Hyperglycemia treatment in hospitalized patients
- Hypoglycemia prevention in hospitalized patients
- Transitioning patients from IV to subcutaneous insulin therapy
- Standardizing insulin dosing protocols in hospitals
- Improving glycemic control and patient safety in hospitals
What Physicians Need to Know
EndoTool SubQ offers a patient-specific approach to insulin dosing, moving beyond traditional sliding-scale protocols to provide individualized and adaptive recommendations. Pay close attention to the system's recommendations, as they are based on a comprehensive analysis of patient variables and are designed to prevent both hypoglycemia and hyperglycemia. The system's ability to facilitate safe transitions from IV to SubQ insulin therapy is a key advantage for managing inpatient diabetes. Utilize the provided training and support to maximize the tool's effectiveness and ensure optimal patient outcomes. Regularly review the analytics provided by EndoTool to assess clinical adoption and identify areas for continuous improvement in glycemic management within your institution.
EndoTool SubQ is designed for integration with existing Electronic Medical Records (EMR) systems, such as Cerner, to streamline workflows and avoid duplicate charting. This integration allows for a more seamless flow of patient data and insulin dosing recommendations. For healthcare facilities where direct EHR integration is not immediately feasible, EndoTool SubQ can also operate as a standalone system, offering flexibility in deployment based on the hospital's infrastructure and needs.
Details
| Category | Endocrinology & Metabolic AI, Pharmacology & Dosing AI |
| Pricing | Contact vendor |
| Deployment | Cloud-based (browser-based) and potentially thick client options. |
| Compliance | |
| BAA Available | Unknown |
| HIPAA Compliant | Unknown |
| FDA Status | Cleared AI-estimated |
| Integrations | |
| EHR | Not specified |
| Specialties | Endocrinology, Hospital Medicine, Pediatrics |
FDA clearance history
This product’s FDA authorization. From FDA’s list of AI-enabled medical devices; each number links to FDA’s record.
| Decision date | Number | Name as listed by FDA |
| 2015-04-24 | K142918 510(k) | EndoTool SubQ |
Ratings & Reviews
No reviews yet. Be the first to review this tool!
Rate EndoTool SubQ
Videos
Product demos, reviews, and walkthroughs for EndoTool SubQ.
Frequently Asked Questions
Compare EndoTool SubQ
VS
VS
VS





